Pain Management

The group discusses Patient Case 1 and how they would treat in this scenario.

Matthew A. Torrington, MD, introduces our first patient case, a 27-year-old man presenting with injuries from a car accident.

Results highlight the impact of education on patient understanding of potential adverse events.

Keeping OTC products near the pharmacy counter creates an opportunity for patient counseling and education.

Patient confidence in CBD products—and pharmacist ability to provide counsel—increased during the study.

In rural settings, patients and providers are frequently reading from different scripts when it comes to managing these conditions

A group of specialists discuss overdoses and treatment with naloxone so family and caregivers are prepared for the future and for treatment.

Dr Kosten describes how to deal with a fentanyl overdose.

Our panel of doctors and pharmacists introduce naloxone, an opioid antagonist, as an option when treating opioid abuse or overdose.

The panel explains the common challenges they find when trying to treat a patient with opioids.

Before seeing a physician, patients can try to treat osteoarthritis pain with OTC remedies.

Four experts delve into pain management and how opioid abuse factors into their decision-making.

A panel of experts discuss the parameters of the opioid epidemic and the role fentanyl plays within it.

The new guidelines come on the heels of the controversial 2016 guidance that placed hard caps on prescribing.

An oral concurrent session at SMFM’s 42nd Annual Pregnancy Meeting highlighted an analysis of pregnancy outcomes after optimal prenatal opioid use disorder care.

Less than 5% of people with migraine have received an accurate diagnosis for this disabling—and painful—disease.

Calcitonin gene-related peptide (CGRP) antagonists are the first class of drugs developed exclusively for migraine prevention.

Preventive medications might be considered in patients with 4 or more migraine days per month.

More than 37 million men, women, and children in the United States are affected by migraine.

Clinicians are seeking ways to reduce opioid exposure in a variety of settings. Could the use of acetaminophen before opioid use reduce opioid treatment duration in the inpatient setting?

Take a look back at the top 10 pain management news articles published on Drug Topics® this year.

Highlights included updates on COVID-19 vaccine tolerance in individuals with rheumatic diseases, the latest data on medical cannabis use in fibromyalgia, and more.

Mean days of therapy per 1000 patient-days were reduced across medication categories.

A coalition of 240 organizations came together to urge Congress to pass legislation to fight the opioid crisis.

By July 2021, the FDA had approved or tentatively approved 470 generic versions of medications.

Small towns have faced everything and overcome all manner of struggles—until the opioid epidemic came to town.

Pharmacists are a key part of the multidisciplinary approach that health care providers should take when tapering patients off opioid therapy.

Patients with fibromyalgia are turning to medical cannabis to improve sleep problems and other negative effects, according to a poster presentation at ACR Convergence 2021, the American College of Rheumatology’s annual meeting.

Nonprescription opioid use can significantly increase the risk of opioid overdose, according to a recent study.

Naloxone education often requires difficult but necessary conversations with patients.